Transaction Date | Recipient | Shares | Type | Price | Value |
---|---|---|---|---|---|
12th June 2019 | Allan L Goldstein | 228,000 | Bona fide gift | $0.00 | |
6th January 2019 | Allan L Goldstein | 208,912 | Conversion of derivative | $0.06 | $12,534.72 |
6th January 2019 | Joseph C Mcnay | 522,280 | Conversion of derivative | $0.06 | $31,336.80 |
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
RegeneRx Biopharmaceuticals, Inc. focuses on the development of a novel therapeutic peptide, Thymosin beta 4, or Tß4. The company was founded by Allan L. Goldstein on May 13, 1982 and is headquartered in Rockville, MD.
6th November 2020
6th November 2020
6th November 2020